Profile data is unavailable for this security.
About the company
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
- Revenue in INR (TTM)8.01bn
- Net income in INR2.31bn
- Incorporated2023
- Employees--
- LocationSanofi Consumer Healthcare India Ltd3Rd Floor, Sanofi HouseMUMBAI 400072IndiaIND
- Phone+91 2 228032000
- Fax+91 2 228032939
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarti Pharmalabs Ltd | 19.68bn | 2.28bn | 58.94bn | 1.63k | 25.85 | 3.17 | 19.20 | 3.00 | 25.16 | 25.16 | 217.12 | 204.88 | 0.7733 | 1.62 | 4.59 | 12,095,750.00 | 8.96 | -- | 11.86 | -- | 45.56 | -- | 11.59 | -- | 0.9611 | 17.12 | 0.1723 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Unichem Laboratories Ltd | 17.28bn | -605.50m | 60.70bn | 3.19k | -- | -- | 116.19 | 3.51 | -8.59 | -8.59 | 245.15 | -- | -- | -- | -- | 5,410,587.00 | -- | -1.67 | -- | -2.03 | 62.00 | 56.18 | -3.50 | -3.99 | -- | 0.1401 | -- | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Sun Pharma Advanced Research Co Ltd | 684.05m | -3.89bn | 66.57bn | 409.00 | -- | -- | -- | 97.32 | -11.97 | -11.97 | 2.11 | -- | -- | -- | -- | 1,672,501.00 | -- | -61.70 | -- | -119.31 | 59.81 | 74.49 | -568.24 | -163.40 | -- | -208.33 | -- | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
| Orchid Pharma Ltd | 8.81bn | 1.12bn | 70.48bn | 872.00 | 60.72 | -- | 48.10 | 8.00 | 22.89 | 22.89 | 180.65 | -- | -- | -- | -- | 10,101,540.00 | -- | -0.9734 | -- | -1.40 | 40.67 | 40.74 | 12.78 | -2.40 | -- | 6.08 | -- | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
| Shilpa Medicare Ltd | 11.84bn | 447.57m | 80.11bn | 931.00 | 164.00 | -- | 52.34 | 6.77 | 5.00 | 5.00 | 133.55 | -- | -- | -- | -- | 12,716,850.00 | -- | 2.84 | -- | 3.65 | 65.19 | 60.08 | 3.79 | 7.03 | -- | 1.56 | -- | 10.76 | 9.66 | 9.44 | 198.15 | -22.26 | -9.26 | -- |
| Blue Jet Healthcare Ltd | 7.22bn | 1.68bn | 81.98bn | 447.00 | 48.84 | 8.87 | 42.80 | 11.36 | 9.68 | 9.68 | 41.61 | 53.27 | 0.6732 | 1.97 | 3.46 | 16,149,080.00 | 15.66 | -- | 19.57 | -- | 55.65 | -- | 23.26 | -- | 2.51 | 131.95 | 0.0012 | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| F D C Ltd | 20.45bn | 3.14bn | 87.40bn | 6.66k | 27.94 | -- | 24.58 | 4.27 | 19.21 | 19.21 | 124.56 | -- | -- | -- | -- | 3,070,786.00 | -- | 12.05 | -- | 13.73 | 65.55 | 61.54 | 15.37 | 15.85 | -- | 75.15 | -- | 1.09 | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
| Procter & Gamble Health Ltd | 11.51bn | 2.01bn | 87.76bn | 1.41k | 43.69 | 16.31 | 38.43 | 7.62 | 121.01 | 121.01 | 693.20 | 324.24 | 1.21 | 2.71 | 11.45 | -- | 21.21 | -- | 29.28 | -- | 71.29 | -- | 17.46 | -- | 1.90 | 386.94 | 0.0175 | -- | -6.37 | -- | -12.42 | -- | -- | -- |
| Sanofi Consumer Healthcare India Ltd | 8.01bn | 2.31bn | 112.24bn | -- | 48.65 | 60.80 | 47.90 | 14.02 | 100.17 | 100.17 | 347.67 | 80.15 | -- | -- | -- | -- | -- | -- | -- | -- | 71.64 | -- | 28.81 | -- | 2.27 | 3,260.00 | 0.0986 | -- | -- | -- | -- | -- | -- | -- |
| Marksans Pharma Ltd | 22.68bn | 3.34bn | 130.01bn | 2.00k | 38.91 | -- | 31.36 | 5.73 | 7.37 | 7.37 | 50.09 | -- | -- | -- | -- | 11,339,960.00 | -- | 14.62 | -- | 18.52 | 53.39 | 50.52 | 14.71 | 14.03 | -- | 32.19 | -- | 6.17 | 17.56 | 16.84 | 17.80 | 32.62 | 73.86 | 64.38 |
| Glenmark Life Sciences Ltd | 22.05bn | 4.24bn | 131.53bn | 2.01k | 31.14 | 5.18 | 27.36 | 5.97 | 34.47 | 34.47 | 179.44 | 207.17 | 0.7304 | 1.46 | 2.79 | 10,947,850.00 | 14.03 | 18.28 | 16.69 | 29.99 | 54.92 | 53.40 | 19.21 | 20.23 | 3.03 | 380.55 | 0.0063 | 26.37 | 5.64 | 20.83 | 0.841 | 19.21 | 69.11 | -- |
| Akums Drugs and Pharmaceuticals Ltd | -100.00bn | -100.00bn | 133.04bn | 7.39k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.32 | -- | -104.25 | -- | -- | -- |
| Granules India Ltd | 47.01bn | 4.92bn | 133.29bn | 4.12k | 27.10 | -- | 18.96 | 2.84 | 20.29 | 20.29 | 193.87 | -- | -- | -- | -- | 11,403,970.00 | -- | 10.68 | -- | 16.18 | 56.89 | 48.83 | 10.47 | 11.82 | -- | 6.95 | -- | 8.96 | -0.123 | 14.61 | -21.54 | 11.38 | 6.38 | 8.45 |
| Strides Pharma Science Ltd | 44.10bn | 1.77bn | 143.53bn | 3.07k | 81.21 | 6.31 | 38.62 | 3.25 | 19.22 | 25.15 | 479.84 | 247.16 | 0.7155 | 1.50 | 3.57 | 14,389,290.00 | 2.79 | -1.68 | 5.43 | -2.97 | 60.19 | 51.39 | 3.91 | -3.36 | 0.6355 | 1.52 | 0.5103 | -- | 9.83 | 13.21 | 43.57 | -- | -18.52 | -3.58 |
| Caplin Point Laboratories Ltd | 17.58bn | 4.78bn | 149.73bn | 859.00 | 31.43 | -- | 27.72 | 8.52 | 62.67 | 62.67 | 230.62 | -- | -- | -- | -- | 20,462,630.00 | -- | 19.83 | -- | 22.82 | 58.41 | 53.38 | 27.43 | 25.39 | -- | 1,525.59 | -- | 9.06 | 15.50 | 21.17 | 21.48 | 20.95 | 17.47 | 17.84 |
| Sanofi India Ltd | 23.83bn | 4.30bn | 153.37bn | 2.17k | 35.68 | 22.40 | 32.77 | 6.44 | 186.62 | 229.86 | 1,034.61 | 297.26 | 1.67 | 2.73 | 15.60 | 10,960,440.00 | 30.08 | 22.42 | 57.55 | 30.21 | 55.95 | 55.52 | 18.04 | 21.03 | 0.8140 | 435.86 | 0.0313 | 135.49 | 2.92 | 0.573 | -2.85 | 9.64 | -10.34 | 14.73 |
Data as of Nov 05 2024. Currency figures normalised to Sanofi Consumer Healthcare India Ltd's reporting currency: Indian Rupee INR
16.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 06 Sep 2024 | 881.06k | 3.83% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 06 Sep 2024 | 758.33k | 3.29% |
| SBI Funds Management Ltd.as of 06 Sep 2024 | 415.37k | 1.80% |
| Bajaj Allianz Life Insurance Co. Ltd.as of 06 Sep 2024 | 385.45k | 1.67% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 351.12k | 1.53% |
| General Insurance Corp. of India (Invt Port)as of 06 Sep 2024 | 330.00k | 1.43% |
| HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 06 Sep 2024 | 320.97k | 1.39% |
| Bajaj Finserv Asset Management Ltd.as of 30 Sep 2024 | 153.50k | 0.67% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 126.63k | 0.55% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 125.04k | 0.54% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
